Cogstate Brief Battery

Add links
From Wikipedia, the free encyclopedia
Cogstate Brief Battery
SynonymsCogstate Schizophrenia Battery

The Cogstate Brief Battery (CBB) is a computer-based cognitive assessment used in clinical trials, healthcare, and academic research to measure neurological cognition.[1][2][3] It was developed by Cogstate Ltd.[4]

Assessment[edit]

The 15-minute assessment consists of four cognitive and neuropsychological tests: Detection, Identification, One Card Learning, and One Back.[5] Each test measures functions in areas such as attention, visual learning, and working memory,[6] and is designed specifically for repeated assessment.

Application[edit]

The assessment has been used to measure change in patients with mild cognitive impairment.[7] and dementia,[1][8] sports-related concussions,[9][10] fatigue,[11][12] and alcohol use,[13] and schizophrenia.[6] It can be taken by adults and children, and has minimal practice effects[5][14][6]

In 2019, Cogstate and Eisai announced a partnership to make the test available outside the United States, for use in health care and other markets.[4][15]

References[edit]

  1. ^ a b Stricker, Nikki H.; Lundt, Emily S.; Albertson, Sabrina M.; Machulda, Mary M.; Pudumjee, Shehroo B.; Kremers, Walter K.; Jack Jr., Clifford R.; Knopman, David S.; Petersen, Ronald C.; Mielke, Michelle M. (2020-01-01). "Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment". Journal of Alzheimer's Disease. 76 (1): 261–274. doi:10.3233/JAD-200087. ISSN 1387-2877. PMC 7546579. PMID 32538841.
  2. ^ Francesco, Davide De; Underwood, Jonathan; Anderson, Jane; Boffito, Marta; Post, Frank A.; Sachikonye, Memory; Mallon, Patrick W. G.; Haddow, Lewis; Vera, Jaime H.; Kunisaki, Ken M.; Sabin, Caroline A. (2020-12-28). "Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individuals". AIDS Care. 33 (10): 1296–1307. doi:10.1080/09540121.2020.1865518. ISSN 0954-0121. PMC 9448413. PMID 33356492. S2CID 229691208.
  3. ^ Koyama, Alain K.; Hagan, Kaitlin A.; Okereke, Olivia I.; Weisskopf, Marc G.; Rosner, Bernard; Grodstein, Francine (2015). "Evaluation of a Self-Administered Computerized Cognitive Battery in an Older Population". Neuroepidemiology. 45 (4): 264–272. doi:10.1159/000439592. ISSN 0251-5350. PMC 4679513. PMID 26501919.
  4. ^ a b "Eisai to develop cognitive function test with Cogstate". www.biospectrumasia.com. Retrieved 2021-08-04.
  5. ^ a b Maruff, Paul; Lim, Yen Ying; Darby, David; Ellis, Kathryn A; Pietrzak, Robert H; Snyder, Peter J; Bush, Ashley I; Szoeke, Cassandra; Schembri, Adrian; Ames, David; Masters, Colin L (2013-12-23). "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease". BMC Psychology. 1 (1): 30. doi:10.1186/2050-7283-1-30. ISSN 2050-7283. PMC 4269990. PMID 25566378.
  6. ^ a b c Zhong, Na; Jiang, Haifeng; Wu, Jin; Chen, Hong; Lin, Shuxing; Zhao, Yan; Du, Jiang; Ma, Xiancang; Chen, Ce; Gao, Chengge; Hashimoto, Kenji (2013-09-02). "Reliability and Validity of the CogState Battery Chinese Language Version in Schizophrenia". PLOS ONE. 8 (9): e74258. Bibcode:2013PLoSO...874258Z. doi:10.1371/journal.pone.0074258. ISSN 1932-6203. PMC 3759436. PMID 24023931.
  7. ^ Patel, Sunita K.; Meier, Adrienne M.; Fernandez, Nathaniel; Lo, Tracy T. Y.; Moore, Colleen; Delgado, Nicole (2017-11-17). "Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer". The Clinical Neuropsychologist. 31 (8): 1375–1386. doi:10.1080/13854046.2016.1275819. ISSN 1385-4046. PMC 5507751. PMID 28080264.
  8. ^ Alden, Eva C.; Pudumjee, Shehroo B.; Lundt, Emily S.; Albertson, Sabrina M.; Machulda, Mary M.; Kremers, Walter K.; Jack, Clifford R.; Knopman, David S.; Petersen, Ronald C.; Mielke, Michelle M.; Stricker, Nikki H. (2021). "Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A+T+) in a population-based sample". Alzheimer's & Dementia. 17 (4): 584–594. doi:10.1002/alz.12219. ISSN 1552-5279. PMC 8371696. PMID 33650308.
  9. ^ Sicard, Veronik; Moore, Robert D.; Ellemberg, Dave (January 2019). "Sensitivity of the Cogstate Test Battery for Detecting Prolonged Cognitive Alterations Stemming From Sport-Related Concussions". Clinical Journal of Sport Medicine. 29 (1): 62–68. doi:10.1097/JSM.0000000000000492. ISSN 1050-642X. PMID 29023272. S2CID 23764316.
  10. ^ "Repetitive Hits to the Head Tied to Depression, Poor Cognition". Medscape. Retrieved 2021-08-04.
  11. ^ Goble, David; Christie, Candice Jo-Anne (2017-06-18). "Cognitive, physical and physiological responses of school boy cricketers to a 30-over batting simulation". Journal of Sports Sciences. 35 (12): 1148–1154. doi:10.1080/02640414.2016.1211731. ISSN 0264-0414. PMID 27467711. S2CID 20528850.
  12. ^ Lupu, Tamar; Braw, Yoram; Sacher, Yaron; Ratmansky, Motti (2021-01-25). "Cogstate Brief Battery: Cognition and the feigning of cognitive impairment in chronic pain". Applied Neuropsychology: Adult. 29 (6): 1332–1343. doi:10.1080/23279095.2021.1873138. ISSN 2327-9095. PMID 33492175. S2CID 231703577.
  13. ^ Falleti, Marina G.; Maruff, Paul; Collie, Alexander; Darby, David G.; McStephen, Michael (2003-12-01). "Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%". Journal of Sleep Research. 12 (4): 265–274. doi:10.1111/j.1365-2869.2003.00363.x. ISSN 0962-1105. PMID 14633237. S2CID 10003172.
  14. ^ Sicard, Veronik; Hergert, Danielle C.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Dodd, Andrew B.; Shaff, Nicholas A.; Stephenson, David D.; Yeates, Keith Owen; Cromer, Jason A.; Campbell, Richard A.; Phillips, John P. (n.d.). "Severity of Ongoing Post-Concussive Symptoms as a Predictor of Cognitive Performance Following a Pediatric Mild Traumatic Brain Injury". Journal of the International Neuropsychological Society. 27 (7): 686–696. doi:10.1017/S1355617720001228. ISSN 1355-6177. PMID 33243310. S2CID 227180771.
  15. ^ "Apellis and Sobi strike a $1.25B deal in rare disease collaboration". www.bioworld.com. Retrieved 2021-08-03.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cogstate_Brief_Battery&oldid=1188129812"